SEC Form 4 · accession 0001209191-17-038957
SYNAPTICS Inc · SYNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey D Buchanan
Director
Period of report
Jun 7, 2017
Accepted (ET)
Jun 9, 2017 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000817720
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2017 | M | 1,172 | $24.20 | A | 7,963 | D | |
| Common Stock | Jun 7, 2017 | M | 3,000 | $23.16 | A | 10,963 | D | |
| Common Stock | Jun 7, 2017 | S | 5,672 | $60.00 | D | 5,291 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy)F2 | $24.20 | Jun 7, 2017 | M | 1,172 | D | — | Oct 26, 2019 | Common Stock | 1,172 | 0 | D |
| Director Stock Option (Right to Buy)F3 | $23.16 | Jun 7, 2017 | M | 3,000 | D | — | Oct 31, 2019 | Common Stock | 3,000 | 0 | D |
Explanation of responses
- F1The shares were sold pursuant to a 10b5-1 Sales Plan dated February 13, 2017.
- F225% of the total number of shares subject to the option vested and became exercisable on the twelve month anniversary of the October 26, 2009 vesting commencement date, and 1/48th of the total number of shares subject to the option vested and became exercisable on the 26th day of each month thereafter until fully vested on October 26, 2013.
- F31/12th of the total number of shares subject to the option vested and became exercisable on the last day of each month until fully vested on October 31, 2013.